Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.36 |
| ▸ | MPO | P05164 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16170881 | 0.98 | ALDH1A1 (0.49) | ALDH1A1MAPTLMNAKMT2AHTR6 | |
| SCHEMBL13347496 | 0.87 | MAPT (0.43) | ALDH1A1MAPTLMNAKMT2AHTR6 | |
| SCHEMBL23865551 | 0.84 | HTR6 (0.42) | ALDH1A1MAPTLMNAKMT2AHTR6 | |
| SCHEMBL45909 | 0.81 | HTR6 (0.59) | ALDH1A1MAPTKMT2AHTR6KDM4E | |
| SCHEMBL28326860 | 0.70 | MET (0.47) | ALDH1A1MAPTKMT2AHTR6SMN1; SMN2 | |
| SCHEMBL21306242 | 0.69 | CALM1 (0.61) | ALDH1A1KDM4ELTB4RHPGDGAA | |
| SCHEMBL6693894 | 0.66 | HTR6 (0.59) | ALDH1A1MAPTKMT2AHTR6KDM4E | |
| SCHEMBL22233466 | 0.66 | CA1 (0.62) | LMNAHTR6 | |
| SCHEMBL15866601 | 0.65 | HTR6 (0.38) | ALDH1A1MAPTLMNAKMT2AHTR6 | |
| SCHEMBL19699730 | 0.65 | HTR6 (0.38) | ALDH1A1MAPTKMT2AHTR6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11711972-B1 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11711972-B1 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | PPOX, ESR1, CCNE2 | ALDH1A1 1004/4885MAPT 1237/4885LMNA 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.